JF
Jad Fakhry
10% Owner

Jad Fakhry insider trades: NovaBay Pharmaceuticals (NBY) stock buys and sales

10% Owner, NovaBay Pharmaceuticals Last trade Apr 8, 2025 13 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2014
4
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jad reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 8, 2025NBY↑ Buy$16K
Apr 1, 2025NBY↑ Buy$75K
Mar 25, 2025NBY↑ Buy$31K
Mar 18, 2025NBY↑ Buy$40K
Mar 7, 2025NBY↑ Buy$30K
Feb 24, 2025NBY↑ Buy$56K
Jan 31, 2025NBY↑ Buy$68K
May 17, 2016SWSH↑ Buy$17K
May 16, 2016SWSH↓ Sell$97K
May 9, 2016SWSH↓ Sell$289K
Aug 3, 2015SCMR↓ Sell$1.7M
Jul 1, 2015EMRI↑ Buy$183K
Oct 10, 2014SCMR↑ Buy$336K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jad Fakhry's insider trades

Jad Fakhry is a 10% owner of NovaBay Pharmaceuticals (NBY). Since Oct 10, 2014, Jad has reported 10 open-market purchases worth $850K and 3 sales worth $2.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NBY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.